Early Detection of Glaucoma and Retinopathy
DP24-081 The Glaucoma and Retinopathy Screening Study
This project aims to find new ways to detect glaucoma early, especially in minority communities, using advanced technology.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Eye and Ear Infirmary NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11174198 on NIH RePORTER |
What this research studies
Glaucoma is a leading cause of blindness, often without symptoms until vision loss is severe, and many people don't know they have it. This project focuses on developing a new screening method that uses artificial intelligence (AI) to analyze eye images, similar to how diabetic eye disease is screened. We hope this approach will make it easier and more affordable to find glaucoma early, particularly for those who are currently underserved. Early detection means that treatments can start sooner, potentially preventing permanent vision loss.
Who could benefit from this research
Good fit: Ideal candidates for future screening efforts would be individuals at risk for glaucoma, particularly those from underserved minority populations who may not have regular access to eye care.
Not a fit: Patients who have already been diagnosed with advanced glaucoma or other severe eye conditions may not directly benefit from this early screening approach.
Why it matters
Potential benefit: If successful, this work could lead to widespread, cost-effective early detection of glaucoma, preventing vision loss for many people, especially in high-risk communities.
How similar studies have performed: Autonomous AI diagnosis has shown success in screening for diabetic eye disease, suggesting a promising foundation for this novel glaucoma screening strategy.
Where this research is happening
Boston, United States
- Massachusetts Eye and Ear Infirmary — Boston, United States (Active)
Researchers
- Principal investigator: Friedman, David S — Massachusetts Eye and Ear Infirmary
- Study coordinator: Friedman, David S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.